If the EGS concept works, drugs containing these compounds could be given to patients prior to their receiving antibiotics, potentially eliminating any drug-resistance they might have. Another possibility, according to Goldberg, is to incorporate the EGS material directly into existing antibiotics. EGS does not appear to be toxic, and bacteria are unlikely to become resistant to it because it's like a Trojan Horse that disables a crucial part of the bacteria's ability to defend itself. Another potential use for EGS is fighting cancers that have become resistant to many chemotherapeutic drugs. Researchers stress that EGS is still years away from possible approval by the Food and Drug Administration.
More animal studies are in the works.
Inc. All Rights Reserved. Terms under which this service is provided to you.